Comments on: Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

Comments on: Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate https://thegbm.com/telix-resubmits-nda-to-u-s-fda-for-tlx101-px-pixclara-brain-cancer-imaging-candidate/ Business news, opinion, reviews, interviews Sun, 15 Mar 2026 21:25:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4